Publications
- New insights to the MLL recombinome of acute leukemias2009 | Second Faculty of Medicine
- Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoring in children with acute lymphoblastic leukaemia?2004 | Second Faculty of Medicine
- Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry2002 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
- Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL2023 | Second Faculty of Medicine, Central Library of Charles University
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | Second Faculty of Medicine
- Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia2023 | Second Faculty of Medicine
- The KMT2A recombinome of acute leukemias in 20232023 | Second Faculty of Medicine
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | Second Faculty of Medicine
- Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol2022 | Second Faculty of Medicine
Loading network view...